Literature DB >> 6847241

Neutrophil chemotaxis in psoriasis before and after PUVA therapy.

B Guillot, J J Guilhou, J P Vendrel, J Meynadier.   

Abstract

Chemokinesis and chemotaxis of neutrophil leucocytes were studied by migration under agarose in 35 patients with psoriasis and compared with 35 healthy controls. Eschericheae coli filtrate and lipopolysaccharide were used as chemo-attractants. Of these patients, 14 were tested before and after photochemotherapy. The chemotactic capacities of psoriatic serum before and after PUVA therapy were also investigated. The increase in the chemotactic activity of psoriatic polymorphonuclear leucocytes (PMNs) was not significant and remained unchanged after PUVA therapy. The activated psoriatic serum showed a slight increase in chemotactic activity when compared with normal activated serum. These results do not support an intrinsic abnormality of psoriatic PMNs, and their migration into psoriatic lesions could be chiefly due to the presence of chemotactic factors in involved epidermis.

Entities:  

Mesh:

Year:  1983        PMID: 6847241     DOI: 10.1007/bf00516549

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  24 in total

Review 1.  Immunopathology of psoriasis.

Authors:  S Jablonska; E H Beutner; W L Binder; M Jarzabek-Chorzelska; G Rzesa; O Chowaniec
Journal:  Arch Dermatol Res       Date:  1979-02-23       Impact factor: 3.017

2.  Demonstration of C3 cleavage product in leukotactic substances of scale extract from pustular psoriasis.

Authors:  H Tagami; S Ofuji
Journal:  Br J Dermatol       Date:  1977-01       Impact factor: 9.302

3.  The role of lymphoid cells and polymorphonuclear leukocytes in the pathogenesis of psoriasis.

Authors:  R H Cormane; J Hunyadi; F Hamerlinck
Journal:  J Dermatol       Date:  1976-10       Impact factor: 4.005

4.  Inflammatory and immune cell function in psoriasis--a subtle disorder I. In vivo and in vitro survey.

Authors:  G G Krueger; H R Hill; W W Jederberg
Journal:  J Invest Dermatol       Date:  1978-09       Impact factor: 8.551

5.  Immunofluorescence in psoriasis: studies of immunoglobulins, complement deposits, and three membrane markers.

Authors:  J J Guilhou; S Malbos; D Delalleau; J Meynadier
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

6.  Chemokinetic and chemotactic factors in psoriasis scale extracts.

Authors:  M V Dahl; W E Lindroos; R D Nelson
Journal:  J Invest Dermatol       Date:  1978-12       Impact factor: 8.551

7.  Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.

Authors:  G Kawohl; B Szperalski; J M Schröder; E Christophers
Journal:  Br J Dermatol       Date:  1980-11       Impact factor: 9.302

8.  Characterization of a leukotactic factor derived from psoriatic scale.

Authors:  H Tagami; S Ofuji
Journal:  Br J Dermatol       Date:  1977-11       Impact factor: 9.302

9.  Effect of 8-methoxypsoralen plus UVA on psoriasis leukotactic factor.

Authors:  N Mizuno; H Enami; K Esaki
Journal:  J Invest Dermatol       Date:  1979-02       Impact factor: 8.551

10.  Studies in immunodermatology. VI. IF studies of autoantibodies to the stratum corneum and of in vivo fixed IgG in stratum corneum of psoriatic lesions.

Authors:  E H Beutner; S Jablonska; M Jarzabek-Chorzelska; E Marciejowska; G Rzesa; T P Chorzelski
Journal:  Int Arch Allergy Appl Immunol       Date:  1975
View more
  1 in total

1.  Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.

Authors:  B Guillot; M Coupe; M Alirezai; J P Bureau; J J Guilhou
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.